- Tytuł:
- Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study
- Autorzy:
- Źródło:
- Breast Cancer. 29(5):796-807
Czasopismo naukowe